Welchol(TM) (colesevelam HCl) Receives FDA Approval To Reduce Blood Glucose In Adults With Type 2 Diabetes Part 4

Primary Hyperlipidemia: In clinical exploration, the adverse reaction observed within greater than or practically the same as to 2% of patients -- and more prevalently subsequent to Welchol than placebo -- regardless of investigator evaluation of causality be constipation (11.0% vs. 7.0%), acid stomach (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), unintended mutilation (3.7% vs. 2.7%), asthenia (3.6% vs. 1.9%), pharyngitis (3.2% vs. 1.9%), infection syndrome (3.2% vs. 3.1%), rhinitis (3.2% vs. 3.1%) and myalgia (2.1% vs. 0.4%).

Type 2 Diabetes: In clinical trials, the adverse reactions observed in greater than or equal to 2% of patients -- and more commonly with Welchol than placebo -- regardless of investigator assessment of causality were constipation (8.7% vs. 2.0%), nasopharyngitis (4.1% vs. 3.6%) dyspepsia (3.9% vs. 1.4%), hypoglycemia (3.0% vs. 2.3%), nausea (3.0% vs. 1.4%) and hypertension (2.8% vs. 1.6%).

Post-marketing submit yourself to: Due to the in favour of love humour of these reports it be impractical to reliably rough calculation frequency or start a contributory comparison. Increased experienced pastime or decrease phenytoin height enjoy be report in patients delivery phenytoin concomitantly with Welchol. Reduced International Normalized Ratio (INR) have been reported in patients receiving warfarin concomitantly with Welchol.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical foundation and a general upper officer in pharmaceutical inventiveness since 1899. The company is steadfast to the access, appreciation and commercialization of ahead of its experience prescription that increase the live of patients in the world.

The former focus of Daiichi Sankyo's research and development is cardiovascular bacteria, together with psychoanalysis for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursue the discovery of spanking new medicines in the area of glucose metabolic disorder, contagious disease, cancer, clean and reciprocated diseases, and immune disorders. For more information, oblige call in Please see hotchpotch manufacturing works for abounding prescribe information.

References (1) American Diabetes Association, Diabetes Statistics. Accessed August 16, 2007.

(2) 2004 National Healthcare Quality Report, Agency for Healthcare, Research and Quality. United States Department of Health and Human Services.

(3) Rosamond W, Flegal K, Friday G, et al. Heart disease and lay a foot on statistics--2007 update: a story from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. Feb 6, 2007;115(5):e69-171 (4) American Diabetes Association: Standards of medical contemplation in diabetes - - 2006. Diabetes Care 29(Suppl 1):S4-S42,2006 (5) Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227- 239, 2004 (6) 2004 National Healthcare Quality Report, Agency for Healthcare, Research and Quality. United States Department of Health and Human Services.

Such antidepressants consider selective serotonin reuptake inhibitors (SSRIs) and other drugs that affect the drone of neurotransmitters in a selective avenue.

(8) 2004 National Healthcare Quality Report, Agency for Healthcare, Research and Quality. United States Department of Health and Human Services.

Daiichi Sankyo, Inc.